NIPT Test
Advanced prenatal screening for chromosomal conditions using a simple blood test.
NIPT Test
(Non-Invasive Prenatal Testing)
The NIPT test is a safe, non‑invasive prenatal screening that analyzes fetal DNA circulating in the mother’s blood. It helps assess the risk of common chromosomal abnormalities early in pregnancy, without posing any risk to the mother or the fetus.
Depending on the selected panel, NIPT can screen for:
Common trisomies (21, 18, 13)
Sex chromosome aneuploidies
Selected microdeletion syndromes
Copy Number Variations (CNVs)
Fetal gender determination
Carrier screening tests identify whether one or both partners carry genetic variations that could lead to inherited disorders. These tests are recommended before or during family planning, IVF, or pregnancy.
Carrier screening test analyzing 30 genes associated with inherited genetic conditions.
- Sample: EDTA blood
- Turnaround time: Approximately 20 days
Extended carrier screening test analyzing more than 100 genes.
- Sample: EDTA blood
- Turnaround time: Approximately 20 days
Comprehensive carrier screening analyzing more than 400 genes, suitable for donor screening.
- Sample: EDTA blood
- Turnaround time: Approximately 20 days
Advanced carrier screening analyzing more than 2,000 genes for inherited disorders.
- Sample: EDTA blood
- Turnaround time: Approximately 20 days
Matching report designed to assess the genetic compatibility between partners and reduce the risk of inherited diseases in IVF treatments.
- Turnaround time: Approximately 10 days
Addition of one specific gene to an existing carrier screening panel.
- Turnaround time: Approximately 10 days
Extension of an existing carrier screening panel:
- Focus → Protect → Easy-Donor → Complete
- Turnaround time: Approximately 10 days
Screens for the most common chromosomal conditions.
Includes:
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Fetal gender
Extended screening including sex chromosome abnormalities.
Includes:
- Trisomies 21, 18, 13
- Fetal gender
- Sex chromosome aneuploidies*
Includes screening for DiGeorge syndrome in addition to common trisomies.
Includes:
- Trisomies 21, 18, 13
- Fetal gender
- Sex chromosome aneuploidies*
- DiGeorge syndrome (22q11.2 deletion)
Enhanced panel with additional trisomies and common microdeletions.
Includes:
- Trisomies 21, 18, 13, 9, 16
- Fetal gender
- Sex chromosome aneuploidies*
- Six common microdeletions ≤ 1MB**
Genome‑wide screening for chromosomal abnormalities.
Includes:
- Trisomies 21, 18, 13
- Fetal gender
- Sex chromosome aneuploidies*
- Copy Number Variations (CNVs ≥ 7MB)
- Analysis of all chromosomes
The most comprehensive NIPT panel available.
Includes:
- Trisomies 21, 18, 13, 9, 16
- Fetal gender
- Sex chromosome aneuploidies*
- Nine common microdeletions ≤ 1MB***
- Copy Number Variations (CNVs ≥ 7MB)
- Analysis of all chromosomes
These tests provide detailed insights into endometrial health, reproductive microbiome balance, immune status, and implantation timing. They are commonly used in fertility evaluation and IVF treatment planning.
Non-invasive test designed to assess markers associated with endometriosis.
- Sample: EDTA blood
- Turnaround time: Approximately 15 days
Evaluation of the reproductive tract microbiome to assess bacterial balance and its impact on fertility.
- Sample: Biopsy
- Turnaround time: Approximately 15 days
Assessment of immunological factors that may influence implantation and pregnancy outcomes.
- Sample: Biopsy
- Turnaround time: Approximately 15 days
Determines the optimal window of implantation to support embryo transfer success.
- Sample: Biopsy
- Turnaround time: Approximately 15 days
Combined analysis of:
- Reproductive microbiome
- Immunological status
- Sample: Biopsy
- Turnaround time: Approximately 15 days
Comprehensive fertility assessment combining:
- Reproductive microbiome
- Immunological status
- Receptivity window
- Sample: Biopsy
- Turnaround time: Approximately 15 days
Book Your Test Now